Investorideas.com breaking new for AI, drones, GPS and technology

Friday, June 26, 2020

#AIEye Episode 377: Veritone (NasdaqGS: $VERI) President Ryan Steelberg Discusses Industry Survey Looking at #AI Adoption in TV Industry



#AIEye Episode 377: Veritone (NasdaqGS: $VERI) President Ryan Steelberg Discusses Industry Survey Looking at #AI Adoption in TV Industry



Point Roberts WA, Vancouver BC – June 26, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

Read this in full at


Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:VERI)

Ryan Steelberg, President of Veritone, Inc. (NasdaqGS:VERI) joined us on The AI Eye for this episode to discuss the state of AI adoption in the TV industry. This was occasioned by a recently-published industry survey, done by Veritone and Future Media Entertainment Group, titled: Pulse Check on AI Adoption, which analyzes AI in television.

To access the report, Pulse Check on AI Adoption, click the link below

Sam Mowers, Investorideas.com


For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


Get more Technology stock investor ideas - news, articles, podcasts and stock directories



Investor Ideas Adds Nasdaq IPO’s in Biotech ( $LEGN, $LTRN, $AMTI, $CALT, $RPRX, $PCVX) and Tech ( $UCL, $VRM)


Investor Ideas Adds Nasdaq IPO’s in Biotech ( $LEGN, $LTRN, $AMTI, $CALT, $RPRX, $PCVX) and Tech ( $UCL, $VRM)






Point Roberts WA, Delta BC, June 26, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including biotech and tech.


This week’s new biotech companies are involved in oncology, autoimmune and renal diseases and novel vaccinations.

The latest tech companies include an e-commerce site for automobiles and a telecom data firm from China.

New Stocks added to Biotech stocks directory
Lantern Pharma Inc. (NasdaqGS:LTRN) is a clinical-stage biopharmaceutical company innovating the repurposing, revitalization and development of precision therapeutics in oncology. We leverage advances in machine learning, genomics, and artificial intelligence by using a proprietary A.I. platform to discover biomarker signatures that help identify patients more likely to respond to our pipeline of cancer therapeutics. Lantern’s focus is to improve the outcome for patients by leveraging our technology to uncover, rescue and develop abandoned or failed drugs. Our current pipeline of three drugs, two in clinical stages and one in preclinical, focuses on cancers that have unique and unmet clinical needs with a clearly defined patient population. We believe that the use of machine learning, genomics and computational methods can help accelerate the revitalization, refocusing and development of small molecule-based therapies. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, this approach represents the potential to deliver best-in-class outcomes. Our team seeks out experienced industry partners, world-class scientific advisors, and innovative clinical-regulatory approaches to assist in delivering cancer therapies to patients as quickly and efficiently as possible.

Legend Biotech Corporation (NasdaqGS:LEGN) is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Our team of over 650 employees across the United States, China and Europe, along with our differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture best-in-class cell therapies for patients in need. We are engaged in a strategic collaboration with Janssen Biotech to develop and commercialize our lead product candidate, LCAR-B38M/JNJ-4528, an investigational BCMA-targeted CAR-T cell therapy for patients living with relapsed or refractory multiple myeloma. This candidate is currently being studied in registrational clinical trials.

Applied Molecular Transport Inc. (NasdaqGS:AMTI) is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing oral biologic product candidates in patient-friendly tablet and capsule forms that are designed for either targeting local gastrointestinal (GI) tissue or entering systemic circulation to precisely address the relevant biology of a disease. AMT is building a portfolio of oral product candidates based on its technology platform including its lead product candidate, AMT-101, an oral GI-selective interleukin 10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). AMT further plans to initiate Phase 2 clinical trials of AMT-101 in UC and related inflammatory indications. AMT’s technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and RNA therapeutics, with potentially significant advantages over existing marketed and development-stage drugs.

Calliditas Therapeutics AB (NasdaqGS:CALT) is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.

Royalty Pharma plc (NasdaqGS::RPRX) Founded in 1996, Royalty Pharma is a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 45 commercial products, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko and Trikafta, and three development-stage product candidates.

Vaxcyte, Inc. (NasdaqGS:PCVX) formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).

New Stocks added to Tech stocks directory
uCloudlink Group Inc. (NasdaqGM:UCL) is the world’s first and leading mobile data traffic sharing marketplace, according to Frost & Sullivan, pioneering the sharing economy business model for the telecommunications industry. The Company’s products and services deliver unique value propositions to mobile data users, handset and smart-hardware companies, mobile virtual network operators (MVNOs) and mobile network operators (MNOs). Leveraging its innovative cloud SIM technology and architecture, the Company has redefined the mobile data connectivity experience by allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace, all while providing reliable connectivity, high speeds and competitive pricing.

Vroom, Inc. (NasdaqGS:VRM) is an innovative, end-to-end ecommerce platform designed to offer a better way to buy and a better way to sell used vehicles. The company's scalable, data-driven technology brings all phases of the vehicle buying and selling process to consumers wherever they are and offers an extensive selection of vehicles, transparent pricing, competitive financing, and contact-free, at-home pick-up and delivery.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.
We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  


Contact Investorideas.com
800 665 0411







Thursday, June 25, 2020

#AIEye Episode 376: FIS (NYSE: $FIS) and FICO (NYSE: $FICO) Partner for ML/AI-Powered Financial Crime Solution, Nuance (NasdaqGS: $NUAN) #AI Marketplace is Accelerating AI Adoption in Radiology



#AIEye Episode 376: FIS (NYSE: $FIS) and FICO (NYSE: $FICO) Partner for ML/AI-Powered Financial Crime Solution, Nuance (NasdaqGS: $NUAN) #AI Marketplace is Accelerating AI Adoption in Radiology

Global Industrial Robots Market to Reach $66.48 Billion by 2027


Point Roberts WA, Vancouver BC – June 25, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:FIS) (NYSE:FICO) (NasdaqGS:NUAN)

The FIS AML Compliance Manager from Fidelity National Information Services, Inc. (NYSE:FIS) has integrated FICO Falcon X technology from Fair Isaac Corporation (NYSE:FICO) to “help financial institutions keep ahead of financial crime.” According to the press release, the solution leverages “machine learning and artificial intelligence to detect suspicious activity and provide detailed, transparent intelligence to bank investigators.” Jim Johnson, head of Global Payments and Wealth at FIS, commented:

"FIS is committed to helping our clients stay one step ahead of financial criminals who are using increasingly sophisticated tools to try to hide illicit money activities through the U.S. financial system. By partnering with FICO, FIS is providing a leading-edge solution to automate routine tasks and reduce false positives that make AML compliance management so challenging, allowing employees to work more efficiently."

Nuance Communications Inc. (NasdaqGS:NUAN) has announced that its Nuance AI Marketplace for Diagnostic Imaging is accelerating AI adoption for radiologists at leading US healthcare systems. Karen Holzberger, Senior Vice President and General Manager of Nuance Healthcare's Diagnostic Division, explained:

"As Nuance and independent industry analysts have often noted, it's not enough to simply develop AI models. You have to support adoption by giving developers a scalable market model, by providing physicians real-time clinical intelligence and solutions that are integrated into their regular workflows, and by addressing healthcare administrators' requirements for security, patient privacy and compatibility with their existing IT infrastructure. The acceleration of the AI Marketplace signals the widespread adoption of AI in radiology using our range of diagnostics solutions.”

Global Industrial Robots Market to Reach $66.48 Billion by 2027

A report from Fortune Business Insights finds that the global Industrial Robots market will grow from $21.83 billion in 2019 to $66.48 billion by 2027 with a compound annual growth rate (CAGR) of 15.1 percent in that forecast period. The report summary highlights the efforts by manufacturers to integrate AI as the market develops, and the following excerpt outlines the role of e-commerce in the market:

The growing trend of consumers towards online shopping is boosting the e-commerce industry. The distribution centers, retailers, warehouses, and facilities owners, are now emphasizing to integrate automated robotic solutions. The interest is to achieve on-time delivery, reduce labor costs, and enhance efficiency and productivity at every process. This is one of the major factors for these robots deployments. Furthermore, many companies are developing promising products across all parts of the logistics value chain, including self-driving trucks, intelligent warehouses, and service robots.

Sam Mowers, Investorideas.com


For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


Get more Technology stock investor ideas - news, articles, podcasts and stock directories


Wednesday, June 24, 2020

#AIEye Episode 375: AWS (NasdaqGS: $AMZN) and #FormulaOne (NasdaqGS: $FWONA) Announce Racing Stats Powered by ML, NVIDIA (NasdaqGS: $NVDA) and Mercedes Plan In-Vehicle #AI Computing Infrastructure




#AIEye Episode 375: AWS (NasdaqGS: $AMZN) and #FormulaOne (NasdaqGS: $FWONA) Announce Racing Stats Powered by ML, NVIDIA (NasdaqGS: $NVDA) and Mercedes Plan In-Vehicle #AI Computing Infrastructure

AI Chip Market in Europe to Reach $16.04 Billion by 2027

Point Roberts WA, Vancouver BC – June 24, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:AMZN) (NasdaqGS:FWONA) (NasdaqGS:NVDA)

Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), and Formula One (NasdaqGS:FWONA), have together announced new racing performance stats for the 2020 season. The “six new, real-time racing statistics,” will leverage “a range of AWS services, including machine learning,” to give fans “more insight into the action on the track with combined driver, race team, and vehicle performance.” Mike Clayville, Vice President, Worldwide Commercial Sales at AWS, explained:

"Formula 1 racing mixes physics and human performance, yielding powerful, but complex data that AWS is helping them to harness. Our existing relationship with F1 has already produced statistics that have brought fans into the race paddocks, and our study of race car aerodynamics is influencing vehicle designs for the 2022 season. This year, we’re thrilled to extend the power of F1 data in the cloud and unlock new insights that help fans understand more of F1’s rich complexity."

NVIDIA Corporation (NasdaqGS:NVDA) is planning to enter a cooperation with Mercedes-Benz to “create a revolutionary in-vehicle computing system and AI computing infrastructure.” Set to roll out in 2024, this will see the fleet of next-gen Mercedes-Benz vehicles enabled with upgradable automated driving functions built on the NVIDIA DRIVE platform. Jensen Huang, founder and CEO of NVIDIA, commented:

“We are excited to work with Mercedes-Benz. It’s the perfect partner for us given its long record of innovation and our strong technical relationship. It’s clear from our extensive discussions with Ola and his team that we share a common vision of the automobile of the future. Together, we’re going to revolutionize the car ownership experience, making the vehicle software programmable and continuously upgradeable via over-the-air updates. Every future Mercedes-Benz with the NVIDIA DRIVE system will come with a team of expert AI and software engineers continuously developing, refining and enhancing the car over its lifetime.”


AI Chip Market in Europe to Reach $16.04 Billion by 2027

A report published by Cue Report finds that the AI Chip market in Europe will grow from $1.25 billion in 2018 to $16.04 billion in 2027 with a compound annual growth rate (CAGR) of 33 percent in the forecast period 2019-2027. An excerpt from the report’s summary outlines drivers in the market:

The considerable investments in artificial intelligence chip start-ups are anticipated to boost the market growth. Real-time consumer behavior insights and increased operational efficiency are driving the adoption of AI across industries that are further driving the growth of the AI chip market. Moreover, the integration of AI chips in edge devices is expected to boost the AI chip market growth in the forecast period. With AI accelerators evolving at an unprecedented rate, new hardware platforms are being optimized to facilitate greater autonomy to edge devices such as mobiles, embedded, and internet of things (IoT) devices. The proliferation of smartphone-embedded AI processors by tech giants like Apple, Samsung, and Google is already gaining traction and driving the growth of [the] AI chip market in edge devices. AI robotics is another noteworthy application of artificial intelligence, which is driving the growth of AI chips in self-driving cars, drones, smart appliances, and industrial IoT.

Sam Mowers, Investorideas.com


For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


Get more Technology stock investor ideas - news, articles, podcasts and stock directories